Periorbital Cellulitis – A Complete Patient Guide
Overview
Periorbital cellulitis (also called pre‑septal cellulitis) is a bacterial infection of the soft tissues around the eye, anterior to the orbital septum. It most often manifests as swelling, redness, and tenderness of the eyelids and surrounding skin. Unlike orbital cellulitis, the infection does **not** involve the fat or muscles behind the eye, which makes it less likely to threaten vision—but it can progress rapidly if not treated.
This condition primarily affects children, especially those between 6 months and 5 years of age, though adults can develop it after facial trauma, surgery, or insect bites. In the United States, periorbital cellulitis accounts for roughly 1–2 cases per 10,000 children annually (CDC, 2022). The incidence peaks during the winter and early spring, coinciding with upper‑respiratory infections that predispose to sinus and eyelid infections.
Symptoms
Symptoms usually appear within 24–48 hours after the inciting event. The classic presentation includes:
- Eyelid swelling – often unilateral, may extend to the cheek.
- Erythema (redness) – the skin looks warm and flushed.
- Tenderness or pain when touching the eyelid.
- Warmth over the affected area.
- Limited eyelid opening (ptosis) due to swelling.
- Conjunctival injection – redness of the white of the eye (less common).
- Normal vision – in true periorbital cellulitis, visual acuity and eye movement remain intact.
- Fever – low‑grade (38–39 °C) in many children; adults may be afebrile.
- General malaise – headache, fatigue, or mild sinus pressure.
If any of the following orbital signs appear, the infection may have spread beyond the septum and requires emergent care (see “When to Seek Emergency Care”): pain with eye movement, double vision, bulging (proptosis), restricted eye movement, or decreased vision.
Causes and Risk Factors
Common Causative Organisms
- Staphylococcus aureus – the most frequent pathogen, including methicillin‑resistant strains (MRSA) in some communities.
- Streptococcus pyogenes (group A streptococcus) – common in pediatric cases.
- Haemophilus influenzae – less common after widespread vaccination.
- Polymicrobial infections – especially after trauma or surgery.
Typical Entry Points
- Primary skin trauma (cuts, abrasions, insect bites).
- Secondary infection from acute sinusitis (especially ethmoid sinus).
- Spread from blepharitis, conjunctivitis, or dacryocystitis.
- Complications of eyelid or facial surgery (e.g., cataract extraction, cosmetic procedures).
Risk Factors
- Age < 5 years – thinner eyelid skin, immature immune system.
- Recent upper‑respiratory infection or sinusitis.
- History of skin conditions (eczema, impetigo).
- Recent facial trauma or surgery.
- Immunocompromised states – diabetes, HIV, chemotherapy.
- Living in communities with high MRSA prevalence.
Diagnosis
Accurate diagnosis relies on a combination of clinical assessment and targeted investigations to rule out orbital cellulitis.
History & Physical Examination
- Onset, progression, and precipitating events.
- Visual acuity test and extra‑ocular movement assessment.
- Palpation for fluctuance (abscess) and measurement of temperature.
Imaging
- CT scan of the orbits (with contrast) – gold standard to confirm the infection is anterior to the orbital septum and to evaluate sinus disease. Sensitivity > 95 % for distinguishing pre‑septal from orbital cellulitis.
- Ultrasound – useful in children when radiation exposure is a concern; can detect fluid collections.
- MRI – reserved for equivocal cases or suspicion of intracranial extension.
Laboratory Tests
- Complete blood count (CBC) – often shows leukocytosis.
- Blood cultures – recommended if systemic signs (fever > 38.5 °C, tachycardia) are present.
- Swab of eyelid discharge – for culture and sensitivity if purulent material is available.
- Inflammatory markers (CRP, ESR) can help gauge severity but are not diagnostic.
Treatment Options
Prompt antimicrobial therapy is the cornerstone of management. Most patients improve within 24–48 hours if treatment is appropriate.
Antibiotic Regimens
Choice depends on age, local resistance patterns, and severity.
- First‑line (uncomplicated cases)
- Children: Clindamycin + Amoxicillin‑clavulanate OR Trimethoprim‑sulfamethoxazole (TMP‑SMX) + Cephalexin (covers MRSA & typical streptococci).
- Adults: Clindamycin + Amoxicillin‑clavulanate OR Vancomycin IV if MRSA prevalence >10 %.
- Severe or hospitalized patients
- IV Vancomycin + Ceftriaxone or Cefotaxime (covers MRSA + gram‑negative organisms).
- Switch to oral antibiotics after 24–48 h of clinical improvement and when afebrile for ≥24 h.
Typical duration: 7–10 days total, with at least 48 h of oral therapy after symptom resolution.
Surgical Interventions
- Incision and drainage of any abscess or fluctuance.
- Drainage of associated sinus disease (endoscopic sinus surgery) if sinusitis is refractory.
Supportive Care & Lifestyle Adjustments
- Warm compresses (10‑15 min, 3‑4 times daily) to reduce edema.
- Analgesics such as acetaminophen or ibuprofen for pain/fever.
- Maintain eyelid hygiene – gentle cleansing with sterile saline.
- Avoid makeup or contact lenses until the infection clears.
Living with Periorbital Cellulitis
Daily Management Tips
- Medication adherence – finish the full antibiotic course even if symptoms improve.
- Monitor vision – any new blurry vision, double vision, or eye pain warrants immediate review.
- Cold‑avoidance – protect the affected eye from wind, dust, and bright light.
- Follow‑up visits – usually within 24‑48 h of starting antibiotics to confirm improvement.
- Hydration and nutrition – support immune function.
Impact on Activities
Most children can return to school after 24 h of appropriate antibiotics and when fever‑free. Adults may need a few days off work, especially if they perform tasks requiring precise visual acuity.
Prevention
- Hand hygiene – wash hands frequently, especially after touching the face.
- Prompt treatment of skin breaks – clean and cover minor cuts or insect bites.
- Manage sinus infections early – use saline nasal irrigation and seek medical care for prolonged sinusitis.
- Vaccinations – maintain up‑to‑date immunizations (e.g., Hib, pneumococcal) that reduce bacterial colonization.
- Avoid sharing eye cosmetics – use individual makeup brushes and discard old products.
- Screen for MRSA carriers in households with recurrent skin infections; decolonization protocols may be advised.
Complications
While periorbital cellulitis is usually benign, delayed or inadequate treatment can lead to serious outcomes:
- Progression to orbital cellulitis – can cause vision loss, ophthalmic artery thrombosis, or cavernous sinus thrombosis.
- Subperiosteal abscess – may require surgical drainage.
- Permanent scarring or skin discoloration.
- Systemic spread – bacteremia, meningitis (rare).
The risk of progression to orbital cellulitis is estimated at 5–10 % in untreated pediatric cases (Mayo Clinic, 2023).
When to Seek Emergency Care
- Rapid swelling that spreads to the bridge of the nose or cheek.
- Pain with eye movement or inability to move the eye.
- Double vision (diplopia) or new visual loss.
- Bulging of the eye (proptosis) or a noticeable change in eye shape.
- Fever > 39 °C (102.2 °F) that does not improve with acetaminophen/ibuprofen.
- Severe headache, neck stiffness, or signs of meningitis.
- Swelling that interferes with breathing or swallowing.
These signs suggest orbital cellulitis or other serious complications that require intravenous antibiotics and possible surgical intervention.
Sources: Mayo Clinic. Periorbital Cellulitis. 2023; Centers for Disease Control and Prevention. Bacterial Infections Overview. 2022; National Institute of Health. Clinical Guidelines for Skin and Soft Tissue Infections. 2021; World Health Organization. Antimicrobial Resistance Fact Sheet. 2022; Cleveland Clinic. Orbital vs. Pre‑septal Cellulitis. 2024.
```